STOCK TITAN

Reliance Global Group (EZRA) Stock Price, News & Analysis

EZRA NASDAQ

Ticker history: RELI became EZRA (Reliance Global Group, Inc.) on . Earlier news and filings retain their original names and dates. View RELI history.

Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
89 252 sessions, November 5, 2025 to November 5, 2026
Largest daily move
+55.6% close of February 9, 2026
1-year change
-94.3% closing prices, November 5, 2025 to November 5, 2026
1-month change
-13.8% closing prices, October 5, 2026 to November 5, 2026

Company Description

Reliance Global Group, Inc. is a Nasdaq-listed holding company that combines insurance agency operations, InsurTech platforms and strategic venture investments. The company has historically focused on acquiring, owning and actively managing wholesale and retail insurance agencies, with insurance commissions forming the core revenue model of its insurance operations. Reliance Global Group is incorporated in Florida and is headquartered in Lakewood, New Jersey.

The company’s operating foundation includes insurance and InsurTech activities built around independent insurance agencies and agency distribution. Its RELI Exchange platform is an InsurTech platform for independent insurance agencies. The platform is designed to support agency recruitment, customer acquisition and agent productivity through a centralized operating environment that includes pipeline stages, task management and communication tracking.

Reliance Global Group also operates EZRA International Group, a strategic growth platform focused on identifying, acquiring and building majority or controlling stakes in high-growth technology companies. The platform is intended to complement the company’s insurance business through active ownership and disciplined capital allocation across adjacent verticals. Recent company materials describe technology and life sciences as areas of focus within this ownership-driven model.

Within technology, Reliance has reported an equity position in Enquantum Ltd., a developer of post-quantum cryptographic solutions and quantum-resilient encryption technology for high-performance environments. The company has described its Enquantum investment as milestone-based, with ownership and governance participation increasing as defined technical and commercial milestones are met.

Within life sciences, Reliance formed LifeSci Global Group LLC, a Delaware limited liability company in which the company holds approximately 51% of the membership interests. LifeSci Global was formed to identify and make investments in healthcare-related companies. Its initial investment is in Innervate Radiopharmaceuticals LLC, a company focused on radiopharmaceutical products and related technologies. Innervate’s lead asset, 18F-mFBG, is being developed as a PET imaging agent for neuroblastoma.

The company’s public-company profile therefore reflects a dual operating structure: an insurance and InsurTech base centered on agency distribution, and a strategic ventures platform centered on ownership positions in technology and healthcare-related businesses. Reliance Global Group’s common stock trades on Nasdaq under the symbol EZRA.

Stock Performance

$2.26
+9.69%
+0.20
After hoursChange vs the $2.06 closeLast updated: November 5, 2026 at 17:03
-94.3%
Performance 1 year

Reliance Global Group (EZRA) closed at $2.06 on November 5, 2026. Over the past 12 months, the price has lost 94.3%.

See what a $1,000 investment in EZRA would be worth today

Average down calculator for EZRA

EZRA Metrics & Rankings

Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Reliance Global Group has 10 recent news articles, with the latest published yesterday. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, AI, earnings, conferences, earnings date. View all EZRA news →

SEC Filings

Reliance Global Group has filed 10 recent SEC filings, including 6 Form 8-K, 2 Form SCHEDULE 13D/A, 1 Form 8-K/A, 1 Form 424B3. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all EZRA SEC filings →

Financial Highlights

Reliance Global Group generated $12.4M in revenue in FY2025, operating income reached -$9.0M (-72.5% operating margin), and net income was -$7.0M, reflecting a -56.2% net profit margin. Diluted earnings per share stood at -$1.28. The company generated -$3.1M in operating cash flow. The current ratio was 1.78, measuring current assets divided by current liabilities.

$12.4M
Revenue (FY2025)
-$7.0M
Net Income (FY2025)
-$3.1M
Operating Cash Flow

Upcoming Events

AUG
31
August 31, 2027 Financial

Earnout measurement date

End of 12-month earnout period for Southwestern Montana Insurance Center; triggers EBITDA-based contingent payment determination.
SEP
03
September 3, 2027 Corporate

Rights Plan Expiration

The rights plan is set to expire on 2027-09-03 unless redeemed or terminated earlier by the Board of Directors.
NOV
01
November 1, 2027 Financial

Contingent deferred payment

Contingent $375,000 payment due 12 months after closing, milestone-dependent and payable if acquisition closes.
JAN
29
January 29, 2028 Financial

Warrants expiration

Warrants exercisable at $0.27 upon issuance; expire two years after closing.
FEB
03
February 3, 2028 - April 2, 2028 Financial

Escrow release payment

$1.65M interest-bearing escrow to be released 18 months after closing; timing depends on closing date under LOI.

Reliance Global Group has 5 upcoming scheduled events. The next event, "Earnout measurement date", is scheduled for August 31, 2027 (in 299 days). 4 of them are financing or capital events, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the EZRA stock price.

Short Interest History

Last 12 Months

Short interest in Reliance Global Group (EZRA) currently stands at 43.6 thousand shares, up 405.0% from the previous reporting period, representing 3.3% of the float.

Days to Cover History

Last 12 Months

Days to cover for Reliance Global Group (EZRA) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

EZRA Company Profile & Sector Positioning

Reliance Global Group (EZRA) operates in the Insurance Brokers industry within the broader Financial Services sector and is listed on the NASDAQ.

Investors comparing EZRA often look at related companies in the same sector, including Zhibao Technology Inc. (ZBAO), Huize Holding Limited (HUIZ), eHealth, Inc. (EHTH), AIFU Inc. (AIFU), and SelectQuote, Inc. (SLQT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EZRA's relative position within its industry.

Frequently Asked Questions

The current stock price of Reliance Global Group (EZRA) is $2.26 in after-hours trading as of November 5, 2026.

The market cap of Reliance Global Group (EZRA) is approximately $3.8M. Learn more about what market capitalization means .

The FY2025 revenue of Reliance Global Group (EZRA) is $12.4M, from its most recent completed fiscal year.

The FY2025 net income of Reliance Global Group (EZRA) is -$7.0M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Reliance Global Group (EZRA) is -$1.28 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Reliance Global Group (EZRA) is -$3.1M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Reliance Global Group (EZRA) is -56.2% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Reliance Global Group (EZRA) is -72.5% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The current ratio of Reliance Global Group (EZRA), current assets divided by current liabilities, was 1.78 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The operating income of Reliance Global Group (EZRA) is -$9.0M for FY2025, its most recent completed fiscal year. Learn about operating income.

Reliance Global Group is a holding company that operates insurance and InsurTech businesses and holds strategic investments in technology and life sciences platforms.

The company's insurance operations earn revenue from insurance commissions tied to wholesale and retail insurance agency activity.

RELI Exchange is Reliance Global Group's InsurTech platform for independent insurance agencies. It supports agency recruiting, customer acquisition and operating workflow through a centralized technology environment.

EZRA International Group is Reliance Global Group's strategic growth platform focused on identifying, acquiring and building majority or controlling stakes in high-growth technology companies.

LifeSci Global Group LLC is a healthcare-focused investment platform in which Reliance Global Group holds approximately 51% of the membership interests. It was formed to identify and make investments in healthcare-related companies.

Innervate Radiopharmaceuticals LLC is a company focused on radiopharmaceutical products and related technologies. Its lead asset, 18F-mFBG, is being developed as a PET imaging agent for neuroblastoma.

Enquantum Ltd. is a developer of post-quantum cryptographic solutions and quantum-resilient encryption technology. Reliance Global Group has reported an equity position in Enquantum.

Reliance Global Group is headquartered in Lakewood, New Jersey, and its common stock trades on Nasdaq under the symbol EZRA.